Interaction of human papillomavirus type 16 L2 with cellular proteins: Identification of novel nuclear body-associated proteins

Virology

Volumn 303, Issue 1, 2002, Pages 69-78

  Görnemann, Janina ^a,c   Hofmann, Thomas G ^b   Will, Hans ^b   Müller, Martin ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

^c MAX PLANCK INSTITUTE OF MOLECULAR CELL BIOLOGY AND GENETICS   (Germany)

Author keywords

HPV; Nuclear bodies; Papillomavirus; PODs; Protein protein interaction; Structural protein

Indexed keywords

CELL PROTEIN; CYTOPLASM PROTEIN; NUCLEAR PROTEIN; VIRUS PROTEIN;

ARTICLE; CELL FUNCTION; CONTROLLED STUDY; HOST CELL; IN VITRO STUDY; IN VIVO STUDY; LIFE CYCLE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TWO HYBRID SYSTEM; VIRUS CLASSIFICATION; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

EID: 0036929734     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2002.1670     Document Type: Article

References (22)

1. Baker, T. S., Newcomb, W. W., Olson, N. H., Cowsert, L. M., Olson, C., and Brown, J. C. (1991). Structures of bovine and human papilloma-viruses. Analysis by cryoelectron microscopy and three-dimensional image reconstruction. Biophys. J. 60(6), 1445-1456.
2. Brömme, N. C., Wex, T., Wex, H., Levy, B., Lipyansky, A., and Brömme, D. (2000). Cloning, characterization, and expression of the human TIN-Ag-RP gene encoding a novel putative extracellular matrix protein. Biochem. Biophys. Res. Commun. 271(2), 474-480.
3. Chen, C., and Okayama, H. (1987). High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell Biol. 7(8), 2745-2752.
4. Day, P. M., Roden, R. B., Lowy, D. R., and Schiller, J. T. (1998). The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domains. J. Virol. 72(1), 142-150.
5. Fallaux, F. J., Kranenburg, O., Cramer, S. J., Houweling, A., Van Ormondt, H., Hoeben, R. C., and Van Der Eb, A. J. (1996). Characterization of 911: A new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum. Gene Ther. 7(2), 215-222.
6. Fedele, M., Benvenuto, G., Pero, R., Majello, B., Battista, S., Lembo, F., Vollono, E., Day, P. M., Santoro, M., Lania, L., Bruni, C. B., Fusco, A., and Chiariotti, L. (2000). A novel member of the BTB/POZ family, PATZ, associates with the RNF4 RING finger protein and acts as a transcriptional repressor. J. Biol. Chem. 275(11), 7894-7901.
7. Fields, S., and Song, O. (1989). A novel genetic system to detect protein-protein interactions. Nature 340(6230), 245-246.
8. Kawana, Y., Kawana, K., Yoshikawa, H., Taketani, Y., Yoshiike, K., and Kanda, T. (2001). Human papillomavirus type 16 minor capsid protein I2 N-terminal region containing a common neutralization epitope binds to the cell surface and enters the cytoplasm. J. Virol. 75(5), 2331-2336.
9. Leder, C., Kleinschmidt, J. A., Wiethe, C., and Müller, M. (2001). Enhancement of capsid gene expression: Preparing the human papil-lomavirus type 16 major structural gene L1 for DNA vaccination purposes. J. Virol. 75(19), 9201-9209.
10. Liu, W. J., Gissmann, L., Sun, X. Y., Kanjanahaluethai, A., Müller, M., Doorbar, J., and Zhou, J. (1997). Sequence close to the N-terminus of L2 protein is displayed on the surface of bovine papillomavirus type 1 virions. Virology 227(2), 474-483.
11. Maul, G. G., Negorev, D., Bell, P., and Ishov, A. M. (2000). Review: Properties and assembly mechanisms of ND10, PML bodies, or PODs. J. Struct. Biol. 129(2-3), 278-287.
12. Müller, M., Gissmann, L., Cristiano, R. J., Sun, X. Y., Frazer, I. H., Jenson, A. B., Alonso, A., Zentgraf, H., and Zhou, J. (1995). Papillomavirus capsid binding and uptake by cells from different tissues and species. J. Virol. 69(2), 948-954.
13. Okun, M. M., Day, P. M., Greenstone, H. L., Booy, F. P., Lowy, D. R., Schiller, J. T., and Roden, R. B. (2001). L1 interaction domains of papillomavirus I2 necessary for viral genome encapsidation. J. Virol. 75(9), 4332-4342.
14. Pero, R., Lembo, F., Palmieri, E. A., Vitiello, C., Fedele, M., Fusco, A., Bruni, C. B., and Chiariotti, L. (2001). PATZ attenuates the RNF4-mediated enhancement of AR-dependent transcription. J. Biol. Chem. 21, 21.
15. Roden, R. B., Day, P. M., Bronzo, B. K., Yutzy, W. H. T., Yang, Y., Lowy, D. R., and Schiller, J. T. (2001). Positively charged termini of the L2 minor capsid protein are necessary for papillomavirus infection. J. Virol. 75(21), 10493-10497.
16. Roden, R. B., Kirnbauer, R., Jenson, A. B., Lowy, D. R., and Schiller, J. T. (1994a). Interaction of papillomaviruses with the cell surface. J. Virol. 68 (11), 7260-7266.
17. Roden, R. B., Weissinger, E. M., Henderson, D. W., Booy, F., Kirnbauer, R., Mushinski, J. F., Lowy, D. R., and Schiller, J. T. (1994b). Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins. J. Virol. 68(11), 7570-7574.
18. Sternsdorf, T., Grotzinger, T., Jensen, K., and Will, H. (1997). Nuclear dots: Actors on many stages. Immunobiology 198(1-3), 307-331.
19. Stubenrauch, F., and Laimins, L. A. (1999). Human papillomavirus life cycle: Active and latent phases. Semin. Cancer Biol. 9(6), 379-386.
20. Trus, B. L., Roden, R. B., Greenstone, H. L., Vrhel, M., Schiller, J. T., and Booy, F. P. (1997). Novel structural features of bovine papillomavirus capsid revealed by a three-dimensional reconstruction to 9 A resolution. Nat. Struct. Biol. 4(5), 413-420.
21. Wex, T., Lipyansky, A., Brömme, N. C., Wex, H., Guan, X. Q., and Brömme, D. (2001). TIN-ag-RP, a novel catalytically inactive cathepsin B-related protein with EGF domains, is predominantly expressed in vascular smooth muscle cells. Biochemistry 40(5), 1350-1357.
22. Zur Hausen, H. (2001). Cervical carcinoma and human papillomavirus: On the road to preventing a major human cancer. J. Natl. Cancer Inst. 93(4), 252-253.